1. Home
  2. FFBC vs IBRX Comparison

FFBC vs IBRX Comparison

Compare FFBC & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFBC
  • IBRX
  • Stock Information
  • Founded
  • FFBC 1863
  • IBRX 2014
  • Country
  • FFBC United States
  • IBRX United States
  • Employees
  • FFBC N/A
  • IBRX N/A
  • Industry
  • FFBC Major Banks
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FFBC Finance
  • IBRX Health Care
  • Exchange
  • FFBC Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • FFBC 2.3B
  • IBRX 2.4B
  • IPO Year
  • FFBC N/A
  • IBRX N/A
  • Fundamental
  • Price
  • FFBC $23.96
  • IBRX $3.15
  • Analyst Decision
  • FFBC Hold
  • IBRX Strong Buy
  • Analyst Count
  • FFBC 4
  • IBRX 5
  • Target Price
  • FFBC $30.00
  • IBRX $11.40
  • AVG Volume (30 Days)
  • FFBC 304.2K
  • IBRX 9.7M
  • Earning Date
  • FFBC 07-24-2025
  • IBRX 05-12-2025
  • Dividend Yield
  • FFBC 4.01%
  • IBRX N/A
  • EPS Growth
  • FFBC N/A
  • IBRX N/A
  • EPS
  • FFBC 2.41
  • IBRX N/A
  • Revenue
  • FFBC $763,576,000.00
  • IBRX $31,222,000.00
  • Revenue This Year
  • FFBC $17.60
  • IBRX $564.61
  • Revenue Next Year
  • FFBC $4.79
  • IBRX $161.88
  • P/E Ratio
  • FFBC $9.94
  • IBRX N/A
  • Revenue Growth
  • FFBC N/A
  • IBRX 10238.41
  • 52 Week Low
  • FFBC $20.59
  • IBRX $1.83
  • 52 Week High
  • FFBC $31.18
  • IBRX $7.63
  • Technical
  • Relative Strength Index (RSI)
  • FFBC 48.75
  • IBRX 66.26
  • Support Level
  • FFBC $23.25
  • IBRX $2.62
  • Resistance Level
  • FFBC $24.20
  • IBRX $2.88
  • Average True Range (ATR)
  • FFBC 0.47
  • IBRX 0.23
  • MACD
  • FFBC -0.11
  • IBRX 0.06
  • Stochastic Oscillator
  • FFBC 38.59
  • IBRX 80.90

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: